No couple seen between bone drugs, colon cancer

<p>NEW YORK (Reuters Health) Women who use certain bone-building drugs competence not have a decreased risk of colon cancer, a new investigate finds notwithstanding before justification suggesting a drugs competence offer some protection.
The drugs, called bisphosphonates, embody brands like Fosamax, Boniva, Reclast and Actonel, along with ubiquitous versions.
They are used to forestall and provide a bone-thinning illness osteoporosis, that especially strikes comparison women. The drugs can also be used to assistance provide cancer that has widespread to a bone from other sites in a body.
Bisphosphonates have been tied to both good and bad side effects.
Research has found after years of use, a drug may, in singular cases, indeed break a skeleton and lead to thighbone fractures or a unpleasant relapse of a jaw bone.
On a other hand, several studies have suggested women who use bisphosphonates competence have a...